Angiex

In July of 2018, Angiex launched an experiment to the International Space Station (ISS) U.S. National Laboratory to test our highly selective cancer therapy that targets both tumor cells and the endothelial cells of tumor blood vessels. Our project was supported by a MassChallenge “Technology in Space Prize,” awarded by the ISS National Laboratory and Boeing.

Created: 2020-05-30

Updated: 2022-02-26

Company - Angiex

Founded
Country
2017
USA
Funding
$32.9M
Website
Angiex
Social
Angiex

Service

Classification
Miscellaneous
Category
Microgravity Science
Fields
Astrobiotech
Status
3) Development
First launch
?

Similar Organizations

Microgravity Workspaces, Microgravity Science, ISS Utilization Service

EXPLOR Space Technologies

3) Development

Microgravity Workspaces, Microgravity Science, ISS Utilization Service

Firefly Biotech

4) Early stage

Microgravity Science, Microgravity Research Payloads

Rhodium Scientific

2) Demonstrated

Space Labs

Microgravity Science, In-Space Manufacturing

Space Labs

4) Early stage